The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cell based assays market report forecasts the cell based assays market size to grow to $36.22 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Cell Based Assays Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Cell Based Assays Market Size Forecast
The global cell based assays market is expected to grow from $22.58 billion in 2022 to $24.61 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cell based assays market size is expected to grow to $36.22 billion in 2027 at a CAGR of 10.1%.

North America held the largest cell based assays market share.

Key Cell Based Assays Market Driver ­– Increase In Evolution
For instance, according to report by Sigma, the return on investment for pharmaceutical companies could drop to 5% considering the current level of late-stage failures, and is an unacceptable level for most companies. Major improvements to high-content systems and data analysis from the cell based assays enable scientists to extract a more information about the cellular response and help take informed decisions during drug discovery, and further driving the market for cell based arrays.

Request for A Sample Of The Global Cell Based Assays Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp

Key Cell Based Assays Market Trend – Inclining Towards Early Phase Predictive Toxicity Testing
Researchers are inclining towards early-phase predictive toxicity testing that prevent late-stage drug failures. Predictive cell toxicity assays are being scaled up to increase screening of compounds in the early phases of drug development, reducing the cost of failure. For instance, Creative Bioarray, a biotech company provides a range of in vitro toxicity services to check drug-induced toxicities that save time and cost by reducing the chance of failure in earlier stage. These advances will make clinical testing easy and reduce the cost of operation.

Cell Based Assays Market Segment
1) By Product & Service: Consumables, Instruments, Services, Software
2) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users
4) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies
5) By Consumables: Reagents And Media, Cells And Cell Lines, Probes And Labels
6) By Instruments: Microplates, Microplate Readers, High Throughput Screening, Liquid Handling Systems

Cell Based Assays Market Major Players and Strategies
Major players in the cell based assays market are Thermo Fisher, Danaher, Becton, Dickinson and Company, GE Healthcare, Merck, Perkinelmer, Promega, Lonza, Charles River Laboratories and Cell Signaling Technology.

In May 2022, Cell Carta, a Canada-based provider of precision medicine laboratory services, acquired next-generation immune-MRM assays from Precision assays for an undisclosed amount. The acquisition will solidify Cell Carta’s position in the proteomics vertical and help it better serve the customers. Precision Assays is a US-based provider of next-generation targeted proteomics testing solutions.

The Cell Based Assays Global Market Report 2023 covers regional data on cell based assays market size, cell based assays market trends and drivers, opportunities, strategies, and cell based assays market competitor analysis. The countries covered in the cell based assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cell based assays are experimental tools that are designed to study reactions taking place inside the cells. These assays are used to study a mechanism or process of cellular function.

View More Reports Related To The Cell Based Assays Market –
Cell Culture Consumables And Equipment Global Market Report 2023
Cell Therapy Global Market Report 2023
Cell Therapy Technologies Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: